Opin vísindi

Browsing by Author "Uhlig, Till"

Browsing by Author "Uhlig, Till"

Sort by: Order: Results:

  • Vasileiadis, Georgios K.; Zhang, Yuan; Fatima, Tahzeeb; van Vollenhoven, Ronald; Lampa, Jon; Guðbjörnsson, Björn; Haavardsholm, Espen A.; Nordström, Dan; Gröndal, Gerður María; Hørslev-Petersen, Kim; Lend, Kristina; Heiberg, Marte S.; Hetland, Merete Lund; Nurmohamed, Michael; Uhlig, Till; Sokka-Isler, Tuulikki; Rudin, Anna; Maglio, Cristina (2024-11-04)
    Objective: The objective of this study was to determine if baseline adiponectin, leptin, and resistin levels are associated with response to antirheumatic treatment in early rheumatoid arthritis (RA). Methods: This study included 341 participants of ...
  • Scheffler, Julia M.; Drevinge, Christina; Lindholm, Catharina; Gjertsson, Inger; Lend, Kristina; Lund Hetland, Merete; Østergaard, Mikkel; Uhlig, Till; Schrumpf Heiberg, Marte; Haavardsholm, Espen A.; Nurmohamed, Michael T.; Lampa, Jon; Sokka-Isler, Tuulikki; Nordström, Dan; Hørslev-Petersen, Kim; Guðbjörnsson, Björn; Gröndal, Gerður María; van Vollenhoven, Ronald; Carlsten, Hans; Lorentzon, Mattias; Hultgård Ekwall, Anna Karin; Rudin, Anna; Islander, Ulrika (2025-01)
    Objective: The high prevalence of osteoporosis in rheumatoid arthritis (RA) is due to inflammation that stimulates differentiation of osteoclasts, a process involving circulating monocytes and T cell–derived factors. The aim of this study was to evaluate ...
  • Dijkshoorn, Bas; Hansildaar, Romy; Vedder, Daisy; Soutari, Nida; Rudin, Anna; Nordström, Dan; Guðbjörnsson, Björn; Lend, Kristina; Uhlig, Till; Haavardsholm, Espen A; Gröndal, Gerður María; Hetland, Merete Lund; Heiberg, Marte Schrumpf; Østergaard, Mikkel; Hørslev-Petersen, Kim; Lampa, Jon; van Vollenhoven, Ronald F; Antovic, Aleksandra; Nurmohamed, Michael T (2024-12-31)
    OBJECTIVES: To assess the effect of treatment on haemostatic parameters in patients with early rheumatoid arthritis (RA). METHODS: Patients with newly diagnosed RA started methotrexate and were randomised to additional conventional treatment, certolizumab ...